Wednesday, December 23, 2009
Arena Atherosclerosis Drug Trial Ends in Disappointment - San Diego Business Journal
Arena Atherosclerosis Drug Trial Ends in Disappointment
San Diego Business Journal
The news sent shares of Arena, traded under the symbol ARNA on the Nasdaq, down 4 percent in after-hours trading at $3.65. The seven-year collaboration ...
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment